These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 31951176)

  • 1. Medication Non-adherence in Patients with Osteoporosis: Implications for Clinical Pharmacists and Osteoporosis Care Providers.
    Jarab AS; Mukattash TL; Hilan H
    Curr Clin Pharmacol; 2020; 15(3):243-250. PubMed ID: 31951176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of non-adherence to pharmacotherapy in patients with type 2 diabetes.
    Jarab AS; Almrayat R; Alqudah S; Thehairat E; Mukattash TL; Khdour M; Pinto S
    Int J Clin Pharm; 2014 Aug; 36(4):725-33. PubMed ID: 24805800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring variables associated with medication non-adherence in patients with COPD.
    Jarab AS; Mukattash TL
    Int J Clin Pharm; 2019 Oct; 41(5):1202-1209. PubMed ID: 31468254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physician perception of patient adherence compared to patient adherence of osteoporosis medications from pharmacy claims.
    Copher R; Buzinec P; Zarotsky V; Kazis L; Iqbal SU; Macarios D
    Curr Med Res Opin; 2010 Apr; 26(4):777-85. PubMed ID: 20095797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid control and its associated factors among patients with dyslipidaemia in Jordan.
    Jarab AS; Alefishat EA; Al-Qerem W; Mukattash TL; Al-Hajjeh DM
    Int J Clin Pract; 2021 May; 75(5):e14000. PubMed ID: 33400313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the Pharmacist in Medication Therapy Management Services in Patients With Osteoporosis.
    Murphy-Menezes M
    Clin Ther; 2015 Jul; 37(7):1573-86. PubMed ID: 25913920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors affecting adherence to osteoporosis medications: a focus group approach examining viewpoints of patients and providers.
    Iversen MD; Vora RR; Servi A; Solomon DH
    J Geriatr Phys Ther; 2011; 34(2):72-81. PubMed ID: 21937896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of patient-led cooperative follow-up by general practitioners and community pharmacists on osteoporosis treatment persistence.
    Poivret D; Goetz C; Zevering Y; Wilcke C; Noirez V
    Int J Rheum Dis; 2021 Jul; 24(7):912-921. PubMed ID: 34058072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural history, reasons for, and impact of low/non-adherence to medications for osteoporosis in a cohort of community-dwelling older women already established on medication: a 2-year follow-up study.
    Clark EM; Gould VC; Tobias JH; Horne R
    Osteoporos Int; 2016 Feb; 27(2):579-90. PubMed ID: 26286625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impacts of a pharmacist-managed outpatient clinic and chemotherapy-directed electronic order sets for monitoring oral chemotherapy.
    Battis B; Clifford L; Huq M; Pejoro E; Mambourg S
    J Oncol Pharm Pract; 2017 Dec; 23(8):582-590. PubMed ID: 27733666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of very low adherence with medications for osteoporosis: towards development of a clinical prediction rule.
    Solomon DH; Brookhart MA; Tsao P; Sundaresan D; Andrade SE; Mazor K; Yood R
    Osteoporos Int; 2011 Jun; 22(6):1737-43. PubMed ID: 20878392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poor medication adherence to bisphosphonates and high self-perception of aging in elderly female patients with osteoporosis.
    Wu X; Wei D; Sun B; Wu XN
    Osteoporos Int; 2016 Oct; 27(10):3083-90. PubMed ID: 27624338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of pharmaceutical care on adherence and persistence to bisphosphonates in postmenopausal osteoporotic women.
    Lai PS; Chua SS; Chew YY; Chan SP
    J Clin Pharm Ther; 2011 Oct; 36(5):557-67. PubMed ID: 21916908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of patient-reported outcomes (PROs): treatment satisfaction, medication adherence, and quality of life (QoL) and the associated factors in postmenopausal osteoporosis (PMO) patients in Korea.
    Byun DW; Moon SH; Kim T; Lee HH; Park HM; Kang MI; Ha YC; Chung HY; Yoon BK; Kim TY; Chae SU; Shin CS; Yang KH; Lee JH; Chang JS; Kim SH; Kim IJ; Koh JM; Jung JH; Yi KW; Yoo JJ; Chung DJ; Lee YK; Yoon HK; Hong S; Kim DY; Baek KH; Kim HJ; Kim YJ; Kang S; Min YK
    J Bone Miner Metab; 2019 May; 37(3):563-572. PubMed ID: 30238428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychometric properties of the Osteoporosis-specific Morisky Medication Adherence Scale in postmenopausal women with osteoporosis newly treated with bisphosphonates.
    Reynolds K; Viswanathan HN; O'Malley CD; Muntner P; Harrison TN; Cheetham TC; Hsu JW; Gold DT; Silverman S; Grauer A; Morisky DE
    Ann Pharmacother; 2012 May; 46(5):659-70. PubMed ID: 22510666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medication non-adherence and the achievement of therapeutic goals of anemia therapy among hemodialysis patients in Jordan.
    Alshogran OY; Shatnawi EA; Altawalbeh SM; Jarab AS; Farah RI
    Hosp Pract (1995); 2022 Feb; 50(1):82-88. PubMed ID: 35061551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistence, adherence, and medication-taking behavior in women with postmenopausal osteoporosis receiving denosumab in routine practice in Germany, Austria, Greece, and Belgium: 12-month results from a European non-interventional study.
    Hadji P; Papaioannou N; Gielen E; Feudjo Tepie M; Zhang E; Frieling I; Geusens P; Makras P; Resch H; Möller G; Kalouche-Khalil L; Fahrleitner-Pammer A
    Osteoporos Int; 2015 Oct; 26(10):2479-89. PubMed ID: 26018090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of pharmacists' interventions on the pharmacotherapy of patients with complex needs monitored in multidisciplinary primary care teams.
    Samir Abdin M; Grenier-Gosselin L; Guénette L
    Int J Pharm Pract; 2020 Feb; 28(1):75-83. PubMed ID: 31468599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of non-adherence among psychiatric patients in Jordan, a cross sectional study.
    Mukattash TL; Alzoubi KH; Abu El-Rub E; Jarab AS; Al-Azzam SI; Khdour M; Shara M; Al Hamarneh YN
    Int J Pharm Pract; 2016 May; 24(3):217-21. PubMed ID: 26809232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adherence to osteoporosis medicines in Estonia-a comprehensive 15-year retrospective prescriptions database study.
    Laius O; Pisarev H; Maasalu K; Kõks S; Märtson A
    Arch Osteoporos; 2017 Dec; 12(1):59. PubMed ID: 28643266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.